Literature DB >> 27656251

Pulmonary hypertension imitating HELLP syndrome.

Adam Morton1.   

Abstract

A case of undiagnosed pulmonary hypertension in a woman with mixed connective tissue disease presenting with microangiopathic haemolysis, thrombocytopenia and elevated liver enzymes imitating severe preeclampsia (HELLP syndrome) is described. Connective tissue disorders are associated with an increased prevalence of pulmonary hypertension. Maternal mortality rates with pulmonary hypertension in pregnancy are extremely high. All women with connective tissue disorders should have pulmonary hypertension excluded by echocardiography before attempting conception. End-stage pulmonary hypertension may be associated with haemolysis and thrombocytopenia and thus may imitate severe preeclampsia in pregnant women. There may be a role for extracorporeal membrane oxygenation in the peripartum management of women with severe pulmonary hypertension.

Entities:  

Keywords:  HELLP syndrome; mixed connective tissue disease; preeclampsia; pregnancy; pulmonary hypertension

Year:  2013        PMID: 27656251      PMCID: PMC5004322          DOI: 10.1177/1753495X13487330

Source DB:  PubMed          Journal:  Obstet Med        ISSN: 1753-495X


  23 in total

1.  Pregnant patient with primary pulmonary hypertension: general anesthesia and extracorporeal membrane oxygenation support for termination of pregnancy.

Authors:  Hitoaki Satoh; Yuichiro Masuda; Shinichiro Izuta; Hideaki Yaku; Hidefumi Obara
Journal:  Anesthesiology       Date:  2002-12       Impact factor: 7.892

Review 2.  Pulmonary arterial hypertension in connective tissue diseases.

Authors:  Shunji Yoshida
Journal:  Allergol Int       Date:  2011-10-25       Impact factor: 5.836

3.  Extracorporeal membrane oxygenation as a bridge to pulmonary endarterectomy.

Authors:  Mohammad Mydin; Marius Berman; Andrew Klein; Steven Tsui; John Dunning; Karmen Valchanov; Alan Vuylsteke; David P Jenkins
Journal:  Ann Thorac Surg       Date:  2011-10-31       Impact factor: 4.330

4.  Pulmonary arterial hypertension in the setting of pregnancy: a case series and standard treatment approach.

Authors:  J Shaun Smith; Julianne Mueller; Curt J Daniels
Journal:  Lung       Date:  2011-12-03       Impact factor: 2.584

5.  Echocardiographic abnormalities and antiphospholipid antibodies in patients with systemic lupus erythematosus.

Authors:  Creso Abreu Falcao; Izabel Cristina Alves; Wiliam Habib Chahade; Angela Luzia Branco Pinto Duarte; Norma Lucena-Silva
Journal:  Arq Bras Cardiol       Date:  2002-09       Impact factor: 2.000

6.  Microangiopathic hemolytic anemia and thrombocytopenia in a child with atrial septal defect and pulmonary hypertension.

Authors:  H Suzuki; M Nakasato; S Sato; S Yokoyama; M Katsuura; S Yamaki; K Hayasaka
Journal:  Tohoku J Exp Med       Date:  1997-03       Impact factor: 1.848

7.  Improved survival in pregnancy and pulmonary hypertension using a multiprofessional approach.

Authors:  D G Kiely; R Condliffe; V Webster; G H Mills; I Wrench; S V Gandhi; K Selby; I J Armstrong; L Martin; E S Howarth; F A Bu'lock; P Stewart; C A Elliot
Journal:  BJOG       Date:  2010-04       Impact factor: 6.531

8.  Primary pulmonary hypertension. Its association with microangiopathic hemolytic anemia and thrombocytopenia.

Authors:  S J Jubelirer
Journal:  Arch Intern Med       Date:  1991-06

9.  Veno-venous extracorporeal membrane oxygenation bridging to pharmacotherapy in pulmonary arterial hypertensive crisis.

Authors:  Mukta C Srivastava; Gautam V Ramani; Jose P Garcia; Bartley P Griffith; Patricia A Uber; Myung H Park
Journal:  J Heart Lung Transplant       Date:  2010-04-22       Impact factor: 10.247

10.  Morphologic features of hepatic injury in cardiac disease and shock.

Authors:  J H Lefkowitch; L Mendez
Journal:  J Hepatol       Date:  1986       Impact factor: 25.083

View more
  1 in total

1.  Mixed connective tissue disease in pregnancy: A case series and systematic literature review.

Authors:  Marie-Lou Tardif; Michèle Mahone
Journal:  Obstet Med       Date:  2018-09-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.